# OPTIMA cost-effectiveness model

The cost-effectiveness model for the OPTIMA prelim trial was constructed in R and takes a very similar structural form to many similar models used for the evaluation of technologies for early breast cancer.
You are welcome to reuse this code, but please cite the publication:

This publication contains a complete description of the model:
>Hall PS, Smith A, Hulme C, Vargas-Palacios A, Makris A, Hughes-Davies L, Dunn JA, Bartlett JM, Cameron DA, Marshall A, Campbell A. Value of information analysis of multiparameter tests for chemotherapy in early breast cancer: the OPTIMA prelim trial. Value in Health. 2017 1;20(10):1311-8.

For more information contact p.s.hall@ed.ac.uk
